Acute Porphyria Drug Database

Monograph

R01AD11 - Triamcinolone
Not porphyrinogenic
NP

Rationale
Insignificant systemic exposure . Several references stating non-porphyrinogenicity of glucocorticoids.
Chemical description
Glucocorticoide nasal spray with very low bioavailability. EPI-list: safe South African list: use Kalman, Bonkowski: safe The Merck Manual: safe Tschudy DP, Lamon JM: Porphyrin metabolism and the porphyrias, in Bondy PK, Rosenberg LE (eds.): Duncan's Diseases of Metabolism. Philadelphia, WB Saunders, 1980, p939: safe Moore MR, Hift RJ: Drugs in the acute porphyrias. Cell Mol Biol 43:89, 1997: safe

Similar drugs
Explore alternative drugs in similar therapeutic classes R01A / R01AD or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Nasacort · Nasacort, 55 microgram/ verstuiving neusspray, suspensie
Belgium
Nasacort · Nasacort 55 µg/dose susp. pulv. nas. flac. pulv.
United Kingdom
Nasacort · Nasacort 55micrograms/dose nasal spray · Nasacort Allergy · Nasacort Allergy 55micrograms/dose nasal spray
Denmark
Nasacort
Norway
Nasacort
Luxembourg
NASACORT · Trinas
Iceland
Nasacort
Finland
Nasacort · Triamcinolone Medipha
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙